Schering GMP investigation
Executive Summary
The Newark, N.J. U.S. Attorney's Office is spearheading a criminal investigation related to Schering-Plough's Puerto Rico production facilities, Schering confirms (1"The Pink Sheet" May 20, p. 5). The investigation reportedly focuses on use of unapproved raw materials...
You may also be interested in...
Schering GMP investigation closed
Newark U.S. attorney's office has closed an investigation on Schering's Puerto Rico manufacturing facility. The inquiry, which was announced in May 2002, focused on the use of unapproved raw materials (1"The Pink Sheet" May 20, 2002, In Brief)...
Schering GMP investigation
FDA/Justice Department investigation of Schering-Plough's GMP compliance at its Manati, P.R. facility is focusing on ribavirin, among other products, firm discloses. The investigation itself was disclosed in May; Schering has not previously identified specific products targeted (1"The Pink Sheet" June 24, 2002, In Brief)...
Schering GMP Criminal Investigation Continues After Consent Decree
Schering-Plough faces a potential criminal case regarding GMP violations after finalizing a consent agreement with FDA May 17
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: